Alexis Carr

Corporate Communications Associate at Abeona Therapeutics - New York, NY, US

Alexis Carr's Colleagues at Abeona Therapeutics
Olga Kourennaia

Scientist, Essay Development

Contact Olga Kourennaia

Yvette Loh

EB Manufacturing Associate

Contact Yvette Loh

Lindsey 'O''Heron'

Associate- AAV Process Development

Contact Lindsey 'O''Heron'

Ruojia Shi

Upstream Process Development Associate

Contact Ruojia Shi

Eva Brotons

Clinical Trial Specialist

Contact Eva Brotons

Dan McCarthy

Sr. Director, Head of Clinical Operations at Abeona Therapeutics

Contact Dan McCarthy

Vishwas Seshadri

Head of Research and Clinical Development

Contact Vishwas Seshadri

View All Alexis Carr's Colleagues
Alexis Carr's Contact Details
Email (Verified)
***@abeonatherapeutics.com
Get Alexis Carr's Email Address
Mobile Number
(XXX) XXX-XXXX
Get Alexis Carr's Mobile Number
HQ
214-665-9495
Location
Company
Abeona Therapeutics
Alexis Carr's Company Details
Abeona Therapeutics logo, Abeona Therapeutics contact details

Abeona Therapeutics

New York, NY, US • 100 - 249 Employees
BioTech/Drugs

Abeona Therapeutics (Nasdaq: ABEO) is a fully-integrated gene and cell therapy company at the forefront of the rapidly-advancing field of genetic medicine. The Company's multi-platform expertise across the manufacture, delivery, development, and discovery of novel gene and cell therapies has it uniquely positioned for success. Underpinning the Company's robust pipeline is its fully-operational manufacturing facility producing therapies and vectors for preclinical and clinical studies. Abeona is also developing the AIM™ Vector Platform: 100+ next-generation AAV capsids for delivering gene therapies targeting a wide range of organs and multiple routes of delivery. A robust and diverse pipeline is led by a novel gene-corrected cell therapy poised to enter Phase 3 in mid-2019 and complemented by one-time gene therapy candidates across four lysosomal storage diseases. Several preclinical discoveries are led by an emerging program in cystic fibrosis that uses the AIM vector platform and a capsid that has shown potential across inherited and acquired retinal diseases.

Gene Therapy Human-derived plasma proteins Biotechnology Pharma Oncology supportive care Ovarian Cancer Alpha-1 deficiency IVIG Ultra orphan proteins Oral Mucositis Rare Disease Sanfiippo Syndrome Type A Sanfiippo Syndrome Type B MPS IIIA juvenile Batten Disease Fanconi anemia Infantile Batten Disease Epidermolysis Bullosa Lysosomal Storage Disease Cell Therapy Pediatric Rare Diseases manufacturing B2B Biotech SaaS Commercial Physical Research
Details about Abeona Therapeutics
Frequently Asked Questions about Alexis Carr
Alexis Carr currently works for Abeona Therapeutics.
Alexis Carr's role at Abeona Therapeutics is Corporate Communications Associate.
Alexis Carr's email address is ***@abeonatherapeutics.com. To view Alexis Carr's full email address, please signup to ConnectPlex.
Alexis Carr works in the Biotechnology industry.
Alexis Carr's colleagues at Abeona Therapeutics are Olga Kourennaia, Yvette Loh, Lindsey 'O''Heron', Ruojia Shi, Eva Brotons, Dan McCarthy, Vishwas Seshadri and others.
Alexis Carr's phone number is 214-665-9495
See more information about Alexis Carr